Background
Little research has been conducted to investigate whether age can modify the impact of hepatitis B virus (HBV) replication on alanine aminotransferase (ALT) levels during pregnancy in women with chronic hepatitis B (CHB). We initially hypothesized that maternal age might modify the relationship between HBV DNA levels and gestational ALT levels.
Methods
In a retrospective cohort study, 1205 pregnant women with CHB delivered at the Second Hospital of Nanjing between January 2021 and January 2023. Our objective was to analyze the association between different levels of HBV DNA and the risk of gestational abnormal ALT levels, adjusting for age using modified Poisson regression.
Results
Our research indicated that individuals with high HBV DNA levels of 2000 IU/ml or higher were more probable to experience abnormal ALT with a relative risk of 2.64 (P < 0.01) and a high ALT level (RR = 1.25, P < 0.01) after adjusting for covariates. Considering the age, women with high HBV DNA aged 35 and above had an even higher risk of gestational abnormal ALT (RR = 3.70, P < 0.01) and a high level of ALT (RR = 1.44, P < 0.01). However, the risk of ALT abnormality in women with low HBV DNA would not modify by age.
Conclusion
Women with CHB may experience significant gestational ALT abnormalities, so they should frequently monitor ALT during pregnancy and receive timely treatment.